These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37371584)

  • 1. Aldosterone: Essential for Life but Damaging to the Vascular Endothelium.
    Crompton M; Skinner LJ; Satchell SC; Butler MJ
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
    Chrissobolis S
    Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid antagonism and cardiac hypertrophy.
    Nagata K
    Curr Hypertens Rep; 2008 Jun; 10(3):216-21. PubMed ID: 18765093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx.
    Butler MJ; Ramnath R; Kadoya H; Desposito D; Riquier-Brison A; Ferguson JK; Onions KL; Ogier AS; ElHegni H; Coward RJ; Welsh GI; Foster RR; Peti-Peterdi J; Satchell SC
    Kidney Int; 2019 Jan; 95(1):94-107. PubMed ID: 30389198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
    Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
    Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
    Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
    Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endothelin-aldosterone axis and cardiovascular diseases.
    Rossi GP; Cavallin M; Nussdorfer GG; Pessina AC
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S49-52. PubMed ID: 11811378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone Effect on Cardiac Structure and Function.
    Al-Hashedi EM; Abdu FA
    Curr Cardiol Rev; 2024; 20(4):e290224227534. PubMed ID: 38425104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.
    Joffe HV; Adler GK
    Heart Fail Rev; 2005 Jan; 10(1):31-7. PubMed ID: 15947889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.
    Brown NJ
    Nat Rev Nephrol; 2013 Aug; 9(8):459-69. PubMed ID: 23774812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone as a Mediator of Cardiovascular Damage.
    Buffolo F; Tetti M; Mulatero P; Monticone S
    Hypertension; 2022 Sep; 79(9):1899-1911. PubMed ID: 35766038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?
    Lyngsø KS; Assersen K; Dalgaard EG; Skott O; Jensen BL; Hansen PB
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):1-10. PubMed ID: 26657712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage.
    Waanders F; de Vries LV; van Goor H; Hillebrands JL; Laverman GD; Bakker SJ; Navis G
    Curr Vasc Pharmacol; 2011 Sep; 9(5):594-605. PubMed ID: 21529330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone as a mediator in cardiovascular injury.
    Stier CT; Chander PN; Rocha R
    Cardiol Rev; 2002; 10(2):97-107. PubMed ID: 11895576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone blockade in cardiovascular disease.
    Struthers AD
    Heart; 2004 Oct; 90(10):1229-34. PubMed ID: 15367532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.